Jeannine Lacroix

Title: Jeannine Lacroix: Innovator in Cancer Research

Introduction

Jeannine Lacroix is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of cancer research, particularly in the therapeutic use of parvoviruses for eliminating cancer stem cells. Her innovative work has garnered attention and respect within the scientific community.

Latest Patents

Jeannine Lacroix holds 2 patents related to her groundbreaking research. One of her latest patents describes the use of parvovirus, preferably H-1PV, for the therapeutic elimination of cancer stem cells (CSCs), specifically targeting neuroblastoma stem cells and glioblastoma stem cells. This innovative approach has the potential to revolutionize cancer treatment by effectively targeting and eliminating the root cause of tumor growth.

Career Highlights

Throughout her career, Jeannine has worked with esteemed institutions such as the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. Her dedication to cancer research has led to significant advancements in understanding and treating various forms of cancer.

Collaborations

Jeannine has collaborated with notable colleagues in her field, including Jean Rommelaere and Joerg Schlehofer. These partnerships have further enhanced her research and contributed to the development of innovative cancer therapies.

Conclusion

Jeannine Lacroix is a trailblazer in cancer research, with her innovative patents and collaborations paving the way for new therapeutic approaches. Her work exemplifies the impact of dedicated research on improving cancer treatment outcomes.